e-learning
resources
London 2016
Wednesday, 07.09.2016
The stage I non-small-cell lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Survival predictors
Paul E. Van Schil (Edegem (Antwerp), Belgium)
Source:
International Congress 2016 – The stage I non-small-cell lung cancer
Session:
The stage I non-small-cell lung cancer
Session type:
Symposium
Number:
4928
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Paul E. Van Schil (Edegem (Antwerp), Belgium). Survival predictors. International Congress 2016 – The stage I non-small-cell lung cancer
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Bernard Yung - 25.09.2016 23:03
Very clear and informative thank you.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Survival characteristics and predictors of mortality in COPD subjects
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
Incidence, predictors and outcomes of weaning
Source: International Congress 2014 – PG18 Weaning off mechanical ventilation: between NIV and tracheotomy
Year: 2014
Survival and predictive factors of mortality in patients with bronchiectasis
Source: Eur Respir J 2006; 28: Suppl. 50, 60s
Year: 2006
Impact on recurrence and long-term survival
Source: Annual Congress 2004 - Impact of neoadjuvant treatments on morbidity and oncological outcome of patients with NSCLC
Year: 2004
Genomic signatures as predictors of progression free and overall survival
Source: Annual Congress 2013 –Biological signatures in thoracic oncology
Year: 2013
Hematological parameters- as mortality predictors in COVID-19 patients
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021
Gender-dependent predictors for survival in patients with COPD
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Heterogeneity of the natural history and predictors of mortality
Source: Annual Congress 2013 –The future of IPF: current mysteries and challenges
Year: 2013
Characteristics and predictors of mortality in patients with pleural infection
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011
Bedside weaning parameters as predictors of outcome
Source: Eur Respir J 2003; 22: Suppl. 45, 380s
Year: 2003
Preoperative Six-Minute-Walk Test in Lung Transplantation: survival predictor
Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome
Year: 2017
Composite Physiological Index as predictor of mortality by using IPF-GAP model
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Prognostic predictors for survival in patients with COPD using cardiopulmonary testing
Source: Eur Respir J 2002; 20: Suppl. 38, 285s
Year: 2002
Admission clinical parameters in predicting in-hospital mortality in COVID-19
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021
Cardiac symptoms are a survival predictor in sarcoidosis
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020
Assessment for risk factors of postoperative empyema in lung cancer operation: A univariate and multivariate analysis
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
Copeptin as a predictor of survival in ventilator associated pneumonia
Source: Annual Congress 2009 - Severe sepsis and multiple organ failure
Year: 2009
The importance of the disease-free survival (DFS) endpoint to survivors of lung cancer
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021
Mortality in bronchiectasis: a long-term study assessing the factors influencing survival
Source: Eur Respir J 2009; 34: 843-849
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept